 Natus Medical Incorporated NASDAQ: NTUS shares are up 25 after the medical device solutions provider for screening, diagnosing and treating disorders that affect the brain sensory nervous systems ad neural pathways signed definitive agreement to be bought by ArchiMed affiliate for 1.2 billion. Shareholders to receive 33.5 per share Stockholders will get 33.50 in cash for ... The post Here is why Natus Medical is up 25 appeared first on Invezz. 